ReSet Therapeutics' Series A Round

ReSet Therapeutics raised a round of funding on December 03, 2013. Investors include Bay City Capital.

ReSet Therapeutics is focused on harnessing the power of the body's internal molecular clocks to discover, develop, and commercialize high-value therapeutics for a variety of disease indications. Mole…

Articles about ReSet Therapeutics' Series A Round: